Ladenburg Thalmann Initiates Coverage On PMV Pharma with Buy Rating, Announces Price Target of $7
Benzinga Newsdesk 2 years ago
NewsPrice TargetInitiationAnalyst Ratings
Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target of $7.
Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target of $7.